The European Medicines Agency has brought forward by six days the date of the meeting at which its drug evaluation committee, the CHMP, is expected to make a recommendation on the approval of Moderna, Inc.’s COVID-19 vaccine, mRNA-1273. This is the second of two such decisions taken by the agency this week.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?